A world-first international trial of hepcidin to regulate iron absorption in haemochromatosis patients is underway, including sites in Brisbane, Sydney and Melbourne. The Phase 2 trial aims to compare weekly dosing of a synthetic human hepcidin versus placebo on markers of iron metabolism. If effective at preventing iron overload, the treatment may be a useful alternative ...
A new approach to iron overload plus new PBAC recommendations
By Mardi Chapman
22 Aug 2018